An2 Therapeutics, INC
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersMenlo Park, CA
SAM.gov UEIDD4FE2GE4L78
AN2 Therapeutics develops novel therapies using a boron chemistry platform, with a pipeline of boron-based compounds targeting hematology, infectious disease, and oncology. The company's drug candidates include Epetraborole and AN2-502998 (oral formulation), which are in clinical trials.
Summarized from the company’s own website
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| An2 Therapeutics, INC | Menlo Park | CA | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.